S&P Global Ratings assigned its'AA-'long-term rating to the North Carolina Medical Care Commission ’s anticipated $127.825 million series 2026A revenue bonds, issued for CaroMont Health . At the same time, we assigned our'AA+/A-1'dual rating and'AA-'underlying rating (SPUR) to the commission’s anticipated $75 million series 2026B-1 and $75 million series 2026B-2 variable rate demand bonds (VRDBs), issued for CaroMont Health. At the same time, we affirmed our'AA-'long-term rating on the commission’s series 2021A tax-exempt revenue bonds, issued for CaroMont Health. Lastly, we affirmed our'AA-'issuer credit rating (ICR) on CaroMont Health. The outlook on the long-term ratings is stable. Gross revenue of the obligated group secures the existing 2021A bonds and the
